HEART AND LUNG THERAPIES
Xenios AG – a Fresenius Medical Care company – is a pioneer in extracorporeal heart & lung support.
Our dedication to improve patients’ lives, drives us to constantly develop high-quality products and application-related service excellence, which allow to replace standard therapies with superior extracorporeal solutions.
On that account Xenios stands for a change of paradigm in intensive-care medicine and forms a significant part of FME’s holistic multi-organ approach.
THE XENIOS CONSOLE
Dedicated technology combines both heart and lung support in one single platform – a platform that is universally usable, individual and compatible with applications of our parent company, Fresenius Medical Care.
Novalung therapy allows to mitigate, prevent or replace mechanical ventilation by extracorporeal gas exchange. It enables caregivers to give the lung time to heal and change the therapy environment in the ICU – from CO2 removal to full oxygenation.
Medos is your partner experienced in cardiopulmonary solutions for more than 30 years: highly skilled employees and high-quality manufacturing, for the benefit of cardiac surgeons, perfusionists and patients.
Our internationally acclaimed clinical support team accompanies the clinical application of all Xenios products. Our specialists trained in intensive care are available on a telephone hotline. The clinical support team also provides support on-site in hospitals during initial applications of Novalung products and offers customized training courses.
LEARNING WITH XENIOS
LOOKING FOR FURTHER THERAPY- AND XENIOS PRODUCT INFORMATION?
Join our Xenios Campus to explore various eLearnings for example expert interviews, best-practice-cases, medical knowledge, hands-on-tutorials, priming instructions and more. Of course, free of charge and without obligation.
ECMO becomes crucial therapy in battle against COVID-19 in Europe
Xenios consoles as lifesavers As the coronavirus spreads and infections with COVID-19 further increase throughout Europe, ECMO therapy turns out to be a necessary option for patients with severe courses. Xenios AG, a subsidiary of Fresenius Medical Care, provides ECMO consoles that can be used for the treatment of patients who ...
Video: How do artificial lungs work?
Xenios had the chance to work together with VRM GmbH & Co. KG, based in Mainz, Germany, to shoot a video about the function of an artificial lung and to explain the importance and the current training situation in China and the USA. VRM is one of the most important ...
Fresenius Medical Care sends more Novalung consoles for ECMO to support Wuhan in battle against COVID-19
Fresenius Medical Care is again supplying medical equipment that is urgently needed to combat the COVID-19 outbreak in Wuhan, including 16 Novalung® consoles, the second such shipment to the Chinese city. Novalung is an extracorporeal membrane oxygenation (ECMO) system from Fresenius Medical Care that pumps and oxygenates a patient’s blood. ...
07. – 10. October
15th European Conference on Pediatric and Neonatal Mechanical Ventilation - Montreux, Switzerland
15. – 18. September
International Symposium on Intensive Care and Emergency Medicine - Brussels, Belgium
06. – 08. May
9th EuroELSO Congress
9th EuroELSO Congress – London, Great Britain
Queen Elizabeth II Congress Centre, LondonBroad Sanctuary – Westminster, London SW1P 3EE